Indeed, OGCs have been described in all histological subtypes of invasive breast carcinoma and even DCIS [2,3,5], but they are most frequently associated with low-grade tumors, showing high expression of hormone receptors (also referred to as luminal A-like breast tumors). The gene discussed is NR4A1; the disease is ductal breast carcinoma in situ.